Home›Stock Screener›Gujarat Inject›Financial Statements

Gujarat Inject Complete Financial Statements

11 Years of Data
2025 - 2015

In FYNone, Gujarat Inject (GUJINJEC) reported revenue ₹12 Cr, net profit ₹1 Cr and EPS ₹0.30, with a net profit margin of 5.3% and ROE of 10.0%. Full financial statements from FY2015 to FY2025 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see GUJINJEC share price screener.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 5.26% 2025 data
EBITDA Margin 5.26% 2025 data
Operating Margin 6.00% 2025 data
Return on Assets 8.33% 2025 data
Return on Equity 10.00% 2025 data

Balance Sheet Ratios

Debt to Equity 1.20 2025 data
Equity Ratio 83.33% 2025 data
Asset Turnover 1.58 2025 data

GUJINJEC Revenue, Net Profit & EBITDA — Year-on-Year Growth

GUJINJEC YoY (March 2025 vs Period) — revenue -36.8%, expenses -38.9%. Explore GUJINJEC Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.

Revenue Growth
-36.8%
Year-over-Year
Expense Growth
-38.9%
Year-over-Year
Assets Growth
+33.3%
Year-over-Year
Equity Growth
+11.1%
Year-over-Year
Liabilities Growth
+33.3%
Year-over-Year

GUJINJEC Income Statement — Revenue, EBITDA & Net Profit

Gujarat Inject revenue ₹12 Cr, EBITDA ₹1 Cr, net profit ₹1 Cr, EPS ₹0.30 (None) — net profit margin 5.3%. Review GUJINJEC P/E comparison to evaluate earnings-based valuation against sector peers.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 12 19 6 1 0 0 0 0 0 2 0 0
Expenses 11 18 6 1 0 0 0 0 0 2 0 0
EBITDA 1 1 0 0 0 0 0 0 0 0 0 0
Operating Profit Margin % 4.00% 6.00% 1.00% -217.00% -200.00% -982.00% 0.00% 0.00% 0.00% 1.00% 4.00% 0.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 1 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 1 1 0 0 0 0 0 0 0 0 0 0
Earnings Per Share (₹) 0.30 0.70 0.09 0.05 0.00 -0.12 0.00 -0.01 -0.03 0.02 4.70 -0.01

GUJINJEC Balance Sheet — Assets, Liabilities & Shareholders' Equity

GUJINJEC total assets ₹12 Cr, total equity ₹10 Cr, total liabilities ₹12 Cr (2025) — ROE 10.0%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 12 9 0 0 0 0 0 0 0 0 0
Current Assets 9 6 0 0 0 0 0 0 0 0 0
Fixed Assets 0 0 0 0 0 0 0 0 0 0 0
Capital Work in Progress 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0
Other Assets 0 9 0 0 0 0 0 0 0 0 0
LIABILITIES
Total Liabilities 12 9 0 0 0 0 0 0 0 0 0
Current Liabilities 0 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 10 9 -1 -1 -1 -1 -1 -1 -1 -1 -3
Share Capital 15 11 5 5 5 5 5 5 5 5 5
Reserves & Surplus -5 -6 -6 -6 -6 -6 -6 -6 -6 -6 -8

GUJINJEC Cash Flow Statement — Operating, Investing & Financing

Gujarat Inject operating cash flow ₹-6 Cr, investing ₹0 Cr, financing ₹9 Cr, net cash flow ₹3 Cr (2024).

Periods ₹ Crores
Particulars March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities -6 0 0 0 0 0 0 0 0 0
Investing Activities 0 0 0 0 0 0 0 0 0 0
Financing Activities 9 0 0 0 0 0 0 0 0 0
Net Cash Flow 3 0 0 0 0 0 0 0 0 0